Ascendis Pharma
ASND
ASND
138 hedge funds and large institutions have $5.41B invested in Ascendis Pharma in 2019 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 41 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
+35
Holders Change %
+33.98%
% of All Funds
2.99%
Holding in Top 10
19
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+46.15%
% of All Funds
0.41%
New
49
Increased
41
Reduced
41
Closed
13
Calls
$230M
Puts
$145M
Net Calls
+$85.3M
Net Calls Change
+$57M
Top Buyers
| 1 |
Millennium Management
New York
|
+$141M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$89.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$65.7M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$65.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$57.6M |
Top Sellers
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$58.9M |
| 2 |
DM
Deerfield Management
New York
|
-$42.5M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$37.5M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$21.8M |
| 5 |
First Manhattan
New York
|
-$19.8M |
